E-LIB Suche - Ergebnisse für: Wennerholm, Agneta

1

Amodiaquine, its desethylated metabolite, or both, inhibit ..:

Wennerholm, Agneta ; Nordmark, Anna ; Pihlsgård, Maria...
European Journal of Clinical Pharmacology. 62 (2006) 7 - p. 539-546 , 2006

Link: https://doi.org/10.1007/..

2

CYP3A5 genotype has significant effect on quinine 3-hydroxy..:

Mirghani, Rajaa A. ; Sayi, Jane ; Aklillu, Eleni...
Pharmacogenetics and Genomics. 16 (2006) 9 - p. 637-645 , 2006

Link: https://doi.org/10.1097/..

3

Simultaneous quantification of alprazolam, 4- and α-hydroxy..:

Allqvist, Annika ; Wennerholm, Agneta ; Svensson, Jan-Olof.
Journal of Chromatography B. 814 (2005) 1 - p. 127-131 , 2005

Link: https://doi.org/10.1016/..

4

Alprazolam as a probe for CYP3A using a single blood sample..:

Wennerholm, Agneta ; Allqvist, Annika ; Svensson, Jan-Olof...
European Journal of Clinical Pharmacology. 61 (2005) 2 - p. 113-118 , 2005

Link: https://doi.org/10.1007/..

5

Analysis of CYP2C9*5 in Caucasian, Oriental and Black-Afric..:

Yasar, �mit ; Aklillu, Eleni ; Canaparo, Roberto...
European Journal of Clinical Pharmacology. 58 (2002) 8 - p. 555-558 , 2002

Link: https://doi.org/10.1007/..

6

Characterization of the CYP2D6*29 allele commonly present i..:

Wennerholm, Agneta ; Johansson, Inger ; Hidestrand, Mats...
Pharmacogenetics. 11 (2001) 5 - p. 417-427 , 2001

Link: https://doi.org/10.1097/..

7

The African‐specific CYP2D6*17 allele encodes an enzyme wit..:

Wennerholm, Agneta ; Dandara, Collet ; Sayi, Jane...
Clinical Pharmacology & Therapeutics. 71 (2001) 1 - p. 77-88 , 2001

Link: https://doi.org/10.1067/..

8

Ten percent of North Spanish individuals carry duplicated o..:

Bernal, Maria Luisa ; Sinues, Blanca ; Johansson, Inger...
Pharmacogenetics. 9 (1999) 5 - p. 657 , 1999

Link: https://doi.org/10.1097/..

9

Decreased capacity for debrisoquine metabolism among black ..:

Wennerholm, Agneta ; Johansson, Inger ; Massele, Amos Y....
Pharmacogenetics and Genomics. 9 (1999) 6 - p. 707-714 , 1999

Link: https://doi.org/10.1097/..

10

Decreased capacity for debrisoquine metabolism among black ..:

Wennerholm, Agneta ; Johansson, Inger ; Massele, Amos Y....
Pharmacogenetics. 9 (1999) 6 - p. 707-714 , 1999

Link: https://doi.org/10.1097/..

11

Ten percent of North Spanish individuals carry duplicated o..:

Bernal, Maria Luisa ; Sinues, Blanca ; Johansson, Inger...
Pharmacogenetics and Genomics. 9 (1999) 5 - p. 657 , 1999

Link: https://doi.org/10.1097/..

12

Bantu Tanzanians have a decreased capacity to metabolize om..:

Herrlin, Karin ; Massele, Amos Y. ; Jande, Mary...
Clinical Pharmacology & Therapeutics. 64 (1998) 4 - p. 391-401 , 1998

Link: https://doi.org/10.1016/..

13

Characteristics of cytochrome P450-catalysed drug metabolis..:

Wennerholm, Agneta
I. Wennerholm A, Johansson I, Massele AY, Lande M, Alm C, Aden-Abdi Y, Dahl ML, Ingelman-Sundberg M, Bertilsson L, Gustafsson LL (1999). Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. Pharmacogenetics. 9(6): 707-14. ::pmid::10634133. , 2003

Link: http://hdl.handle.net/10..